Open Access

3,4,5‑Trihydroxycinnamic acid exerts anti‑inflammatory effects on TNF‑α/IFN‑γ‑stimulated HaCaT cells

  • Authors:
    • Ji-Won Park
    • Jae-Hoon Oh
    • Daseul Hwang
    • Seong-Man Kim
    • Jae-Hong Min
    • Ji-Yun Seo
    • Wanjoo Chun
    • Hee Jae Lee
    • Sei-Ryang Oh
    • Jae-Won Lee
    • Kyung-Seop Ahn
  • View Affiliations

  • Published online on: May 11, 2021     https://doi.org/10.3892/mmr.2021.12148
  • Article Number: 509
  • Copyright: © Park et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

3,4,5‑Trihydroxycinnamic acid (THCA) exhibits anti‑inflammatory activity in acute or chronic inflammatory disorders, such as acute lung injury and asthma. The present study investigated the anti‑inflammatory activity of THCA in a tumor necrosis factor‑α/interferon‑γ (TI) mixture‑stimulated human keratinocyte cell line. The results of ELISA and reverse transcription‑quantitative PCR revealed that THCA reduced the secretion and mRNA expression levels of interleukin (IL)‑6; IL‑8; thymus and activation‑regulated chemokine; macrophage‑derived chemokine; regulated upon activation, normal T cell expressed and secreted; and monocyte chemoattractant protein‑1 in TI mixture‑stimulated HaCaT cells. In addition, the results of western blot analysis demonstrated that THCA exerted inhibitory activity on the activation of AKT, ERK and nuclear factor‑κB in TI mixture‑stimulated HaCaT cells. Furthermore, THCA upregulated the expression levels of heme oxygenase‑1 and NAD(P)H:quinone oxidoreductase 1, and the activation of nuclear factor erythroid 2‑related factor 2 in HaCaT cells. These results demonstrated that THCA may exhibit anti‑inflammatory activity in activated HaCaT cells.

Introduction

Atopic dermatitis (AD) is a chronic inflammatory disease characterized by severe itching and is caused by genetic and environmental factors, including microbial infection (1). Keratinocyte-derived cytokines and chemokines, such as interleukin-6 (IL-6), IL-8, thymus and activation-regulated chemokine (TARC), macrophage-derived chemokine (MDC), regulated upon activation, normal T cell expressed, and secreted (RANTES) and monocyte chemoattractant protein-1 (MCP-1), are closely related to the pathophysiology of AD (24). It is known that the combination of tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) induces the expression of inflammatory cytokines and chemokines in keratinocytes (57). The activation of AKT/MAPK/NF-κB is known to be associated with the production of inflammatory molecules, including IL-6, IL-8, TARC, MDC, RANTES and MCP-1, in TNF-α/IFN-γ (TI)-stimulated HaCaT cells (4,5,8,9). A previous study reported that antioxidants exert protective effects in AD by regulating the activation of mitogen-activated protein kinase (MAPK) and nuclear factor-κB (NF-κB) (10).

The anti-inflammatory properties of caffeic acid derivatives have been demonstrated in various studies (11,12). 3,4,5-Trihydroxycinnamic acid (THCA), a derivative of caffeic acid, exerts anti-inflammatory activity in activated BV2 microglia, RAW264.7 macrophages and A549 airway epithelial cells (1316). In these studies, THCA also exerted protective effects in experimental animal models of sepsis, acute lung injury and allergic asthma. However, its effect and molecular mechanisms have not been examined in activated keratinocytes. Therefore, in the present study, we examined whether THCA regulates the TI mixture-induced inflammatory response in HaCaT cells.

Materials and methods

Cell culture

HaCaT cells, the human keratinocyte cell line, were purchased from CLS Cell Lines Service and cultured in DMEM containing 10% fetal bovine serum (HyClone; GE Healthcare Life Sciences), 100 U/ml penicillin and 100 µg/ml streptomycin at 37°C in a 5% CO2 atmosphere. HaCaT cells were incubated with 3,4,5-trihydroxycinnamic acid (AApin Chemicals Limited) (2.5, 5, 10, 25, 50 and 100 µM) for 24 h. An MTT assay was used to determine cell viability based on a previous study (1).

Reverse transcription-quantitative PCR (RT-qPCR)

Cells were plated in 12-well plates (1×104 cells/per well), pretreated with THCA (5, 10, 25 and 50 µg/ml) for 30 min, and subsequently administered TNF-α (10 ng/ml, Invitrogen; Thermo Fisher Scientific, Inc.) and IFN-γ (10 ng/ml, Merck KGaA) and maintained for 6 h at 37°C. The extraction of total RNA, synthesis of cDNA and relative mRNA levels of cytokines and chemokines were determined as described previously (1). Primer sequences are listed in Table I. GAPDH was used as the housekeeping gene.

Table I.

Primer sequences used for reverse transcription-quantitative PCR.

Table I.

Primer sequences used for reverse transcription-quantitative PCR.

GeneForward primer sequence (5′→3′)Reverse primer sequence (5′→3′)
IL-6 GACAGCCACTCACCTCTTCA AGTGCCTCTTTGCTGCTTTC
IL-8 ATGACTTCCAAGCTGGCCGTGGCT TTATGAATTCTCAGCCCTCTTCAAAAA
TARC CACGCAGCTCGAGGGACCAATGTG TCAAGACCTCTCAAGGCTTTGCAGG
MDC AGGACAGAGCATGGCTCGCCTACAGA TAATGGCAGGGAGGTAGGGCTCCTGA
RANTES CTGCCTCCCCATATTCCTCGG GAGTTGATGTACTCCCGAACCC
MCP-1 TCTGTGCCTGCTGCTCATAG CAGATCTCCTTGGCCACAAT
GAPDH CCTCCAAAATCAAGTGG CCATCCACAGTCTTCTGG

[i] IL, interleukin; TARC, thymus and activation-regulated chemokine; MDC, macrophage-derived chemokine; RANTES, regulated upon activation, normal T cell expressed and secreted; MCP-1, monocyte chemoattractant protein-1.

Enzyme-linked immunosorbent (ELISA) assay

Cells were plated in 96-well plates (5×105 cells/per well), pretreated with THCA (5, 10, 25 and 50 µg/ml) for 30 min, subsequently treated with 10 ng/ml TNF-α/IFN-γ (TI) and incubated for 24 h at 37°C. The secretion levels of IL-6, IL-8, TARC, RANTES, MDC and MCP-1 in culture media were detected using commercial ELISA kits.

Isolation of nuclear and cytoplasmic proteins

Cells were seeded in growth medium at a density of 1×105 cells/per well in 60-mm cell culture dishes and incubated with THCA for 30 min. Then, TI mixture was administered to each well, and the plates were maintained for 1 h. Nuclear and cytoplasmic proteins were isolated using a protein extraction kit (cat. no. 71183, Merck) according to the manufacturer's instructions.

Western blotting

To determine the phosphorylation of AKT, MAPK and NF-κB, cells were plated in 60-mm cell culture dishes (1×105 cells/well), pretreated with THCA for 30 min, and subsequently maintained with TI mixture for 1 h. To detect the phosphorylation of nuclear factor erythroid 2-related factor 2 (Nrf2) and the expression of HO-1/NQO1, cells were plated in 60-mm cell culture dishes (1×105 cells/well) and maintained with THCA for 1 or 16 h. Cell lysates were prepared using lysis buffer (C-3228; Sigma-Aldrich; Merck KGaA). The protein equivalents of samples were separated by 10–12% SDS polyacrylamide gels and transferred to polyvinylidene fluoride (PVDF) membranes. Five percent skim milk was used as a blocking solution for each membrane. Then, membranes were probed with primary antibodies as follows: Anti-phosphorylated (p)-AKT (4060S), anti-p-ERK (9101S), anti-p-JNK (4668S), anti-p-p38 (9211S), anti-p-NF-κB p65 (3033S), AKT (4691S), ERK (9102S), JNK (9252S), p38 (9212S), NF-κB p65 (8242S), anti-β-actin (4967S; all, 1:1,000; Cell Signaling Technology, Inc.), anti-HO-1 (27338), anti-p-IκB (1;1,000; 15087; Invitrogen; Thermo Fisher Scientific, Inc.), anti-LaminA/C (1;1,000; sc-376248; Santa Cruz Biotechnology, Inc.), anti-NQO1, (1;1,000; N5288; Sigma-Aldrich), anti-p-Nrf2 (1;1,000; NBP2-67465; Novus Biologicals) and anti-Nrf2 (1:1,000; 137550; Abcam). Subsequently, each membrane was exposed to HRP-conjugated secondary antibodies and developed with an ECL solution (Thermo Fisher Scientific, Inc.) The visualization of all bands was performed using the image analyzer, and the density of each band was determined using ImageJ.

Immunocytochemistry

The conditions of cell seeding and fixation were based on a previous study (1). Cells were washed with PBS, blocked in 3% BSA for 1 h at RT and then maintained with the anti-NF-κB p65 subunit (1:250; Cell Signaling Technology, Inc.) or anti-Nrf2 (1:250; Abcam) for 24 h at 4°C. Then, the cells were washed with PBS and maintained with Alexa Fluor 488-conjugated goat anti-rabbit IgG (1:250; Invitrogen; Thermo Fisher Scientific, Inc.) for 1 h at RT. Finally, cells were stained with Gold Antifade reagent containing DAPI (Invitrogen; Thermo Fisher Scientific, Inc.) for 5 min and were subsequently visualized using a confocal microscope.

Statistical analysis

One-way analysis of variance followed by Tukey's post hoc test was used to determine significant differences between the TI group and the THCA treated groups (SPSS Statistics 20; IBM Corp.). Data are expressed as the means ± standard deviation (SD).

Results

Effect of THCA on IL-6 and IL-8 in activated HaCaT cells

To examine the inhibitory effect of THCA treatment on IL-6 and IL-8, MTT assays were first conducted. As presented in Fig. 1A, no noticeable reduction in cell viability was observed following treatment with 2.5–50 µg/ml THCA. The secretion levels of IL-6 and IL-8 were evaluated with an ELISA. As presented in Fig. 1B and C, the production of these molecules was notably increased by TI mixture administration in HaCaT cells, whereas THCA pretreatment exerted inhibitory activity on TI mixture-induced upregulation of IL-6 and IL-8. As shown in Fig. 1D and E, RT-qPCR revealed that the administration of TI resulted in significant upregulation of IL-6 and IL-8 mRNA expression in HaCaT cells. However, THCA pretreatment reduced this upregulation.

Effects of THCA on TARC and MDC in activated HaCaT cells

The TI mixture markedly increased the secretion of TARC and MDC, whereas this increase was reduced by THCA pretreatment (Fig. 2A and B). Next, the mRNA levels of these molecules were determined using RT-qPCR. As shown in Fig. 2C and D, the increases in the mRNA levels of each molecule were confirmed following administration of the TI mixture. THCA pretreatment decreased this increase (Fig. 2C and D).

Effects of THCA on RANTES and MCP-1 in activated HaCaT cells

The TI mixture-induced notable increases in RANETS and MCP-1 secretion were significantly blocked by THCA pretreatment (Fig. 3A and B). In addition, THCA inhibited the increased mRNA expression levels of RANETS and MCP-1 in TI mixture-stimulated HaCaT cells (Fig. 3C and D).

Effects of THCA on AKT and MAPK phosphorylation in activated HaCaT cells

Western blotting results showed that AKT and MAPK (ERK, JNK and p38) phosphorylation levels were increased by administration of the TI mixture in HaCaT cells (Fig. 4A and B). Pretreatment with THCA resulted in suppression of AKT and ERK phosphorylation in TI-stimulated HaCaT cells. However, the phosphorylation levels of JNK and p38 were not affected by THCA pretreatment.

Effect of THCA on NF-κB p65 phosphorylation in activated HaCaT cells

Next, the effects of THCA on NF-κB p65 and IκBα activation were examined by western blotting. As shown in Fig. 5A and B, THCA treatment attenuated the phosphorylation of NF-κB p65/IκBα in TI mixture-stimulated HaCaT cells. THCA exerted a suppressive effect on the nuclear translocation of NF-κB p65 (Fig. 5C and D). This effect of THCA on nuclear translocation was confirmed using immunocytochemistry (ICC) (Fig. 5E).

Effects of THCA on HO-1 and NQO1 induction in HaCaT cells

As presented in Fig. 6, THCA treatment significantly upregulated the expression of heme oxygenase-1 (HO-1) in HaCaT cells (Fig. 6A and B). THCA treatment also resulted in upregulation of NAD(P)H:quinone oxidoreductase 1 (NQO1) expression in HaCaT cells. Furthermore, Nrf2 activation and nuclear translocation were also increased by THCA treatment (Fig. 6A-D). This ability of THCA on nuclear translocation was confirmed using ICC (Fig. 6E).

Discussion

In the present study, the inhibitory effect of THCA on AD-like markers and its molecular mechanism were studied in vitro using HaCaT human keratinocytes. Accumulating evidence has reported that an increased levels of IL-6 and IL-8 are involved in the pathogenesis of AD and is closely associated with the promotion of keratinocyte proliferation and migration (3,17,18). Inflammatory chemokines have been reported to control the migration of inflammatory cells to sites of infection and inflammation; however, sustained levels of chemokines, such as TARC, MDC, RANTES and MCP-1, are associated with the initiation and disease severity of AD (5,1922). Considering all these reports, the suppression of inflammatory cytokines and chemokines could lead to the amelioration of AD symptoms. As mentioned earlier, the mixture of TI has been used to induce an inflammatory response in human keratinocytes, such as HaCaT cells (5,6); therefore, we selected the TI mixture as an inducer and evaluated the anti-inflammatory effect of THCA. In the present study, the experimental results showed that THCA ameliorates the production of IL-6, IL-8, TARC, MDC, RANTES and MCP-1 in activated HaCaT cells (Figs. 13). These results indicate that THCA exerts anti-inflammatory activity in activated HaCaT cells.

Accumulated evidence has shown that the production of inflammatory cytokines and chemokines is associated with the AKT/MAPK/NF-κB signaling pathways in experimental atopic models (1,4,7). Thus, these signaling pathways represent therapeutic targets for the improvement of AD. Previous studies have shown the inhibitory activity of THCA on NF-κB in lipopolysaccharide-stimulated BV2 microglia and RAW264.7 cells (13,14). Recently, its inhibitory effect was confirmed on AKT/MAPK/NF-κB in activated A549 cells (15). In this study, THCA effectively decreased the activation of AKT, ERK, JNK, p38 and NF-κB in stimulated-A549 cells and exerted inhibitory effects on AKT, ERK, JNK and NF-κB in lung of asthmatic mice (15). THCA also significantly reduced the activation of ERK and p38 in lung of COPD-like mice (16). In these studies, the regulatory effects of THCA on AKT and MAPK was excellent. Furthermore, the regulatory effects of THCA on MAPK activation were confirmed in both in vitro and in vivo. Thus, we expected this effect of THCA on AKT, MAPK and NF-κB to be confirmed in this study. However, no modulatory effects were found on p-JNK and p-38. Considering that THCA did not totally exert the regulatory effect in both JNK (16) and p38 (15) activation in previous studies, it was not surprising that THCA only exerts an inhibitory effect on ERK activation in the present study. Thus, this result indicated that THCA have inhibitory effect on AKT, ERK and NF-κB activation in TNF-α/IFN-γ stimulated HaCaT cells. Collectively, regulatory ability of THCA on AKT/ERK/NF-κB may contribute the amelioration of inflammatory response induced by TI stimulation in the present study (Figs. 4 and 5).

Antioxidant proteins, such as HO-1 and NQO1, exert anti-inflammatory properties in HaCaT cells (23,24). Researchers have reported that the induction of HO-1 ameliorates the inflammatory response in activated HaCaT cells by reducing TARC and MDC expression levels and regulating NF-κB nuclear translocation (25,26). NQO1 was shown to be related to antimelanogenic efficacy in UVA-irradiated keratinocytes (27). Thus, HO-1 and NQO1 are recognized as protective molecules in AD (28). Nrf2 has an important role in HO-1 and NQO1 expression (29). In this study, THC showed inhibitory effects on inflammatory molecules and AKT/ERK/NF-κB phosphorylation in activated HaCaT cells (Figs. 15). Based on these results, we studied whether THCA leads to the induction of HO-1/NQO1 and the activation of Nrf2. We confirmed that THCA induces HO-1/NQO1 expression and Nrf2 activation in HaCaT cells (Fig. 6). Thus, this ability of THCA may be associated with amelioration of the inflammatory response in activated HaCaT cells. However, it is uncertain whether THCA directly affect NF-κB nuclear translocation.

In the previous studies, THCA exerted strong anti-inflammatory properties in LPS-stimulated RAW264.7 macrophages (14) and this study also showed the protective effect of THC on LPS-induced endotoxemia mice. In addition, THCA had anti-inflammatory properties in PMA-stimulated airway epithelial cells (15) and protective effects on COPD like mice and allergic asthma mice (15,16). In the present study, we confirmed that THCA has anti-inflammatory effects in TNF-α/IFN-γ-stimulated HaCaT cells. Collectively, these results indicated that THCA could ameliorate the inflammatory response in various inflammatory diseases. Thus, this experimental approach will support the validity that THCA has a variety of anti-inflammatory actions.

In summary, THCA exerted anti-inflammatory activities on TI-stimulated HaCaT cells (Fig. 7). In particular, its inhibitory effects on important AD markers were excellent, and its regulatory effects on AKT/ERK/NF-κB activation were also remarkable. Furthermore, THCA upregulated the activation of Nrf2 and the expression of antioxidant proteins. Therefore, our results suggest that THCA can be used as an adjuvant in AD. However, further experiments are needed to prove the ameliorative effect in AD animal models.

Acknowledgements

Not applicable.

Funding

The present study was supported by a grant from the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program (grant no. KGM5522113) and the Bio & Medical Technology Development Program of the National Research Foundation (NRF) and the Korean government (MSIT) (grant. no. NRF2020R1A2C2101228).

Availability of data and materials

All data generated and/or analyzed during the present study are included in this published article.

Authors' contributions

JWP designed the present study, performed the in vitro experiments, and made substantial contributions to the analysis and interpretation of data. JHO and DH performed the in vitro experiments and made substantial contributions to the analysis and interpretation of data. SMK, JHM and JYS contributed to data analysis. WC, HJL and SRO made substantial contributions to the conception and design of the present study. JWL and KSA designed the present study, wrote the manuscript and was involved in revising it critically for important intellectual content. All authors discussed the results, and read and approved the final version of the manuscript.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Park JW, Lee HS, Lim Y, Paik JH, Kwon OK, Kim JH, Paryanto I, Yunianto P, Choi S, Oh SR and Ahn KS: Rhododendron album Blume extract inhibits TNF-α/IFN-γ-induced chemokine production via blockade of NF-κB and JAK/STAT activation in human epidermal keratinocytes. Int J Mol Med. 41:3642–3652. 2018.PubMed/NCBI

2 

Huang WC, Dai YW, Peng HL, Kang CW, Kuo CY and Liou CJ: Phloretin ameliorates chemokines and ICAM-1 expression via blocking of the NF-κB pathway in the TNF-α-induced HaCaT human keratinocytes. Int Immunopharmacol. 27:32–37. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Kwon DJ, Bae YS, Ju SM, Goh AR, Choi SY and Park J: Casuarinin suppresses TNF-α-induced ICAM-1 expression via blockade of NF-κB activation in HaCaT cells. Biochem Biophys Res Commun. 409:780–785. 2011. View Article : Google Scholar : PubMed/NCBI

4 

Xiong X, Huang C, Wang F, Dong J, Zhang D, Jiang J, Feng Y, Wu B, Xie T and Cheng L: Qingxue jiedu formulation ameliorated DNFB-induced atopic dermatitis by inhibiting STAT3/MAPK/NF-κB signaling pathways. J Ethnopharmacol. 270:1137732020. View Article : Google Scholar : PubMed/NCBI

5 

Kong L, Liu J, Wang J, Luo Q, Zhang H, Liu B, Xu F, Pang Q, Liu Y and Dong J: Icariin inhibits TNF-α/IFN-γ induced inflammatory response via inhibition of the substance P and p38-MAPK signaling pathway in human keratinocytes. Int Immunopharmacol. 29:401–407. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Lee HS, Park JW, Kwon OK, Lim Y, Kim JH, Kim SY, Zamora N, Rosales K, Choi S, Oh SR and Ahn KS: Anti-inflammatory effects of ethanol extract from the leaves and shoots of Cedrela odorata L. in cytokine-stimulated keratinocytes. Exp Ther Med. 18:833–840. 2019.PubMed/NCBI

7 

Lee da H and Lee CS: Flavonoid myricetin inhibits TNF-α-stimulated production of inflammatory mediators by suppressing the Akt, mTOR and NF-κB pathways in human keratinocytes. Eur J Pharmacol. 784:164–172. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Yang JH, Yoo JM, Lee E, Lee B, Cho WK, Park KI and Yeul Ma J: Anti-inflammatory effects of Perillae herba ethanolic extract against TNF-α/IFN-γ-stimulated human keratinocyte HaCaT cells. J Ethnopharmacol. 211:217–223. 2018. View Article : Google Scholar : PubMed/NCBI

9 

Lee KS, Chun SY, Lee MG, Kim S, Jang TJ and Nam KS: The prevention of TNF-α/IFN-γ mixture-induced inflammation in human keratinocyte and atopic dermatitis-like skin lesions in Nc/Nga mice by mineral-balanced deep sea water. Biomed Pharmacother. 97:1331–1340. 2018. View Article : Google Scholar : PubMed/NCBI

10 

Aye A, Song YJ, Jeon YD and Jin JS: Xanthone suppresses allergic contact dermatitis in vitro and in vivo. Int Immunopharmacol. 78:1060612020. View Article : Google Scholar : PubMed/NCBI

11 

Armutcu F, Akyol S, Ustunsoy S and Turan FF: Therapeutic potential of caffeic acid phenethyl ester and its anti-inflammatory and immunomodulatory effects (Review). Exp Ther Med. 9:1582–1588. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Choi HG, Tran PT, Lee JH, Min BS and Kim JA: Anti-inflammatory activity of caffeic acid derivatives isolated from the roots of Salvia miltiorrhiza bunge. Arch Pharm Res. 41:64–70. 2018. View Article : Google Scholar : PubMed/NCBI

13 

Lee JW, Choi YJ, Park JH, Sim JY, Kwon YS, Lee HJ, Kim SS and Chun W: 3,4,5-Trihydroxycinnamic acid inhibits lipopolysaccharide-induced inflammatory response through the activation of Nrf2 pathway in BV2 microglial cells. Biomol Ther (Seoul). 21:60–65. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Lee JW, Bae CJ, Choi YJ, Kim SI, Kwon YS, Lee HJ, Kim SS and Chun W: 3,4,5-Trihydroxycinnamic acid inhibits lipopolysaccharide (LPS)-induced inflammation by Nrf2 activation in vitro and improves survival of mice in LPS-induced endotoxemia model in vivo. Mol Cell Biochem. 390:143–153. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Park JW, Kim SM, Min JH, Kim MG, Kwon OK, Hwang D, Oh JH, Park MW, Chun W, Lee HJ, et al: 3,4,5-Trihydroxycinnamic acid exerts anti-asthmatic effects in vitro and in vivo. Int Immunopharmacol. 88:1070022020. View Article : Google Scholar : PubMed/NCBI

16 

Min JH, Kim MG, Kim SM, Park JW, Chun W, Lee HJ, Oh SR, Ahn KS and Lee JW: 3,4,5-Trihydroxycinnamic acid exerts a protective effect on pulmonary inflammation in an experimental animal model of COPD. Int Immunopharmacol. 85:1066562020. View Article : Google Scholar : PubMed/NCBI

17 

Sawamura D, Meng X, Ina S, Sato M, Tamai K, Hanada K and Hashimoto I: Induction of keratinocyte proliferation and lymphocytic infiltration by in vivo introduction of the IL-6 gene into keratinocytes and possibility of keratinocyte gene therapy for inflammatory skin diseases using IL-6 mutant genes. J Immunol. 161:5633–5639. 1998.PubMed/NCBI

18 

Gallucci RM, Sloan DK, Heck JM, Murray AR and O'Dell SJ: Interleukin 6 indirectly induces keratinocyte migration. J Invest Dermatol. 122:764–772. 2004. View Article : Google Scholar : PubMed/NCBI

19 

Lim HS, Jin SE, Kim OS, Shin HK and Jeong SJ: Alantolactone from saussurea lappa exerts antiinflammatory effects by inhibiting chemokine production and STAT1 phosphorylation in TNF-α and IFN-γ-induced in HaCaT cells. Phytother Res. 29:1088–1096. 2015. View Article : Google Scholar : PubMed/NCBI

20 

Gros E, Bussmann C, Bieber T, Förster I and Novak N: Expression of chemokines and chemokine receptors in lesional and nonlesional upper skin of patients with atopic dermatitis. J Allergy Clin Immunol. 124:753–760.e1. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Kim HH, Bae Y and Kim SH: Galangin attenuates mast cell-mediated allergic inflammation. Food Chem Toxicol. 57:209–216. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Pivarcsi A and Homey B: Chemokine networks in atopic dermatitis: Traffic signals of disease. Curr Allergy Asthma Rep. 5:284–290. 2005. View Article : Google Scholar : PubMed/NCBI

23 

Huang CH, Chang LC, Hu S, Hsiao CY and Wu SJ: Spilanthol inhibits TNF-α-induced ICAM-1 expression and pro-inflammatory responses by inducing heme oxygenase-1 expression and suppressing pJNK in HaCaT keratinocytes. Mol Med Rep. 18:2987–2994. 2018.PubMed/NCBI

24 

Kleszczyński K, Ernst IMA, Wagner AE, Kruse N, Zillikens D, Rimbach G and Fischer TW: Sulforaphane and phenylethyl isothiocyanate protect human skin against UVR-induced oxidative stress and apoptosis: Role of Nrf2-dependent gene expression and antioxidant enzymes. Pharmacol Res. 78:28–40. 2013. View Article : Google Scholar

25 

Kim H, Youn GS, An SY, Kwon HY, Choi SY and Park J: 2,3-Dimethoxy-2′-hydroxychalcone ameliorates TNF-α-induced ICAM-1 expression and subsequent monocyte adhesiveness via NF-kappaB inhibition and HO-1 induction in HaCaT cells. BMB Rep. 49:57–62. 2016. View Article : Google Scholar : PubMed/NCBI

26 

Jeong SI, Choi BM and Jang SI: Sulforaphane suppresses TARC/CCL17 and MDC/CCL22 expression through heme oxygenase-1 and NF-κB in human keratinocytes. Arch Pharm Res. 33:1867–1876. 2010. View Article : Google Scholar : PubMed/NCBI

27 

Hseu YC, Chen XZ, Vudhya Gowrisankar Y, Yen HR, Chuang JY and Yang HL: The skin-whitening effects of Ectoine via the suppression of α-MSH-stimulated melanogenesis and the activation of antioxidant Nrf2 pathways in UVA-irradiated keratinocytes. Antioxidants (Basel). 9:632020. View Article : Google Scholar : PubMed/NCBI

28 

Chen L and Zhong JL: MicroRNA and heme oxygenase-1 in allergic disease. Int Immunopharmacol. 80:1061322020. View Article : Google Scholar : PubMed/NCBI

29 

Choi M, Park M, Lee S, Lee JW, Choi WJ and Lee C: Establishment of Nrf2-deficient HaCaT and immortalized primary human foreskin keratinocytes and characterization of their responses to ROS-induced cytotoxicity. Toxicol In Vitro. 61:1046022019. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

July-2021
Volume 24 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Park J, Oh J, Hwang D, Kim S, Min J, Seo J, Chun W, Lee HJ, Oh S, Lee J, Lee J, et al: 3,4,5‑Trihydroxycinnamic acid exerts anti‑inflammatory effects on TNF‑α/IFN‑γ‑stimulated HaCaT cells. Mol Med Rep 24: 509, 2021.
APA
Park, J., Oh, J., Hwang, D., Kim, S., Min, J., Seo, J. ... Ahn, K. (2021). 3,4,5‑Trihydroxycinnamic acid exerts anti‑inflammatory effects on TNF‑α/IFN‑γ‑stimulated HaCaT cells. Molecular Medicine Reports, 24, 509. https://doi.org/10.3892/mmr.2021.12148
MLA
Park, J., Oh, J., Hwang, D., Kim, S., Min, J., Seo, J., Chun, W., Lee, H. J., Oh, S., Lee, J., Ahn, K."3,4,5‑Trihydroxycinnamic acid exerts anti‑inflammatory effects on TNF‑α/IFN‑γ‑stimulated HaCaT cells". Molecular Medicine Reports 24.1 (2021): 509.
Chicago
Park, J., Oh, J., Hwang, D., Kim, S., Min, J., Seo, J., Chun, W., Lee, H. J., Oh, S., Lee, J., Ahn, K."3,4,5‑Trihydroxycinnamic acid exerts anti‑inflammatory effects on TNF‑α/IFN‑γ‑stimulated HaCaT cells". Molecular Medicine Reports 24, no. 1 (2021): 509. https://doi.org/10.3892/mmr.2021.12148